Isabela Bruna Pires Borges

Universidade de São Paulo (USP). Faculdade de Medicina (FM) (Institutional affiliation from the last research proposal)
Birthplace: Brazil

Abstract
The present study is a complement to the Master's project, whose objective was to evaluate the safety of atorvastatin in patients with Systemic Autoimmune Myopathies (SAM). In a randomized, double-blind, placebo-controlled clinical trial, 14 patients with SAM received atorvastatin calcium (20 mg/day) and 6 patients with SAM received one tablet - placebo/day for a period of 12 weeks. The m…
Molecular and metabolic analysis of Atorvastatin in the muscle tissues of patients with Systemic Autoimmune Myopathies, BP.DR
Abstract
Dermatomyositis (DM) and polymyositis (PM) are idiopathic inflammatory myopathies characterized by the presence of progressive proximal muscle weakness of limbs. Metabolic syndrome (MS) is a series of biochemical and physiological disorders characterized by fasting plasma glucose change, central obesity, dyslipidemia and hypertension. The clinical relevance of MS is related to its role in…
Effect of lipid-lowering drugs on endothelial function and vascular stiffness in patients with dermatomyositis and polymyositis: a prospective, double-blind, randomized controlled trial, BP.MS
Abstract
The idiopathic inflammatory myopathies (IIM) are a heterogeneous group of chronic autoimmune disease, systemic, associated with high morbidity and functional disability. Considering the clinical and histopathological features, the MII can be classified into polymyositis (PM), dermatomyositis (DM), inclusion body myositis (IBM), among others. The cause of both DM and PM remains unknown, bu…
Characterization of autoantibody anti-melanoma differentiation associated gene 5 (anti-MDA5) in patients with dermatomyositis and polymyositis, BP.IC

Source:Lattes Curriculum

CV Lattes ORCID

3 / 3	Completed scholarships in Brazil

Associated processes

Short URL

Compartilhe esta página

Abstract

Abstract

Abstract